Intellia Therapeutics will cut about 27% of its workforce, or roughly 142 jobs, this year in a cost-savings push intended to support its operations into the first half of 2027, when it expects to ...
Shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) fell 2.4% in pre-open trading Friday as the company announced a strategic reorganization focusing on key valu ...
To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Intellia Therapeutics will stop work on one of its principal drug research programs and lay off more than ...
Some results have been hidden because they may be inaccessible to you